TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis.

[1]  J. Hsieh,et al.  Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer. , 2022, Immunity.

[2]  D. Massi,et al.  Bright-Field Multiplex Immunohistochemistry Assay for Tumor Microenvironment Evaluation in Melanoma Tissues , 2022, Cancers.

[3]  M. Fiorentino,et al.  SOX2 and PRAME in the "reprogramming" of seminoma cells. , 2022, Pathology, research and practice.

[4]  Qing Ji,et al.  Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression , 2022, Frontiers in Immunology.

[5]  K. Tamada,et al.  The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma , 2022, Cancer Immunology, Immunotherapy.

[6]  M. Chovanec,et al.  Comprehensive Assessment of Selected Immune Cell Subpopulations Changes in Chemotherapy-Naïve Germ Cell Tumor Patients , 2022, Frontiers in Oncology.

[7]  H. Reichardt,et al.  A Coculture Model Mimicking the Tumor Microenvironment Unveils Mutual Interactions between Immune Cell Subtypes and the Human Seminoma Cell Line TCam-2 , 2022, Cells.

[8]  N. Kumari,et al.  Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies , 2022, Journal of experimental & clinical cancer research : CR.

[9]  N. Grishin,et al.  Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis , 2022, bioRxiv.

[10]  H. Tsuda,et al.  Gene expression microarray analysis of adult testicular germ cell tumor: a comparison between pure-type seminomas and seminoma components in mixed tumors , 2021, Virchows Archiv.

[11]  T. Koshimizu,et al.  The PRAME family of cancer testis antigens is essential for germline development and gametogenesis , 2021, Biology of Reproduction.

[12]  P. Albers,et al.  The pioneer and differentiation factor FOXA2 is a key driver of yolk‐sac tumour formation and a new biomarker for paediatric and adult yolk‐sac tumours , 2021, Journal of cellular and molecular medicine.

[13]  Ting Zhang,et al.  Tumor-Associated Macrophages in Tumor Immunity , 2020, Frontiers in Immunology.

[14]  M. Chovanec,et al.  Immunotherapy in Testicular Germ Cell Tumors , 2020, Frontiers in Oncology.

[15]  F. V. von Eyben,et al.  Meta-Analysis of Gene Expressions in Testicular Germ Cell Tumor Histologies , 2020, International journal of molecular sciences.

[16]  L. Morrison,et al.  Brightfield multiplex immunohistochemistry with multispectral imaging , 2020, Laboratory Investigation.

[17]  G. Kristiansen,et al.  Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate , 2020, International journal of cancer.

[18]  Yichi Xu,et al.  The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer , 2020, Cell proliferation.

[19]  R. Trisolini,et al.  Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study , 2020, Therapeutic advances in medical oncology.

[20]  S. Asioli,et al.  Prognostic Impact of MCPyV and TIL Subtyping in Merkel Cell Carcinoma: Evidence from a Large European Cohort of 95 Patients , 2019, Endocrine Pathology.

[21]  P. Lal,et al.  Differences in PD-L1-Expressing Macrophages and Immune Microenvironment in Testicular Germ Cell Tumors. , 2019, American journal of clinical pathology.

[22]  J. Maurício,et al.  Detailed Characterization of Immune Cell Infiltrate and Expression of Immune Checkpoint Molecules PD-L1/CTLA-4 and MMR Proteins in Testicular Germ Cell Tumors Disclose Novel Disease Biomarkers , 2019, Cancers.

[23]  Cheng-long Huang,et al.  PD-L1 expression on tumor-infiltrating immune cells is highly associated with M2 TAM and aggressive malignant potential in patients with resected non-small cell lung cancer. , 2019, Lung cancer.

[24]  Huiyin Lan,et al.  Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications , 2019, Journal of Hematology & Oncology.

[25]  R. Boldrini,et al.  Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors , 2018, Oncoimmunology.

[26]  C. Moreira-Barbosa,et al.  DNA methylation profiling as a tool for testicular germ cell tumors subtyping. , 2018, Epigenomics.

[27]  J. Kim,et al.  Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling , 2017, Oncoimmunology.

[28]  H. Schorle,et al.  The plasticity of germ cell cancers and its dependence on the cellular microenvironment , 2017, Journal of cellular and molecular medicine.

[29]  P. Babál,et al.  Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors , 2017, Oncotarget.

[30]  G. Kristiansen,et al.  The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas , 2016, British Journal of Cancer.

[31]  N. Neuhaus.  PRAME as diagnostic marker and as regulator for cell fate decisions in germ cell cancers , 2016, British Journal of Cancer.

[32]  A. Hofmann,et al.  SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate , 2016, Oncotarget.

[33]  I. Wistuba,et al.  Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma , 2016, Clinical Cancer Research.

[34]  L. Looijenga,et al.  Role of SOX2 in the Etiology of Embryonal Carcinoma, Based on Analysis of the NCCIT and NT2 Cell Lines , 2014, PloS one.

[35]  Luciane T. Kagohara,et al.  PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival , 2013, Cancer Immunology Research.

[36]  Honglin Zhou,et al.  Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells. , 2012, Molecular cell.

[37]  J. Aréchaga,et al.  The role of microenvironment in testicular germ cell tumors , 2010, Cancer biology & therapy.

[38]  H. Okabe,et al.  DNMT3L Is a Novel Marker and Is Essential for the Growth of Human Embryonal Carcinoma , 2010, Clinical Cancer Research.

[39]  H. Stoop,et al.  Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications , 2008, The Journal of pathology.

[40]  Harini Chakravarthy,et al.  Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes† , 2007, Nucleic acids research.

[41]  L. Looijenga,et al.  Current views on the pathogenesis of testicular germ cell tumours and perspectives for future research: Highlights of the 5th Copenhagen Workshop on Carcinoma in situ and Cancer of the Testis , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[42]  A. Rizzino,et al.  Role of the transcription factor Sox‐2 in the expression of the FGF‐4 gene in embryonal carcinoma cells , 1998, Molecular reproduction and development.

[43]  E B Cox,et al.  Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. , 1985, Archives of pathology & laboratory medicine.

[44]  OUP accepted manuscript , 2021, American Journal of Clinical Pathology.